Dr. Jay Kranzler
Dr. Kranzler is Chairman Emeritus, Founder, and former Chairman & CEO of Cypress Biosciences, Inc., which focuses on pain and central nervous system conditions. Dr. Kranzler developed a fibromyalgia syndrome drug from concept to market, including the design of clinical trials and regulatory path through Phase III trials and FDA approval. Dr. Kranzler is a recent recipient of the Award for Innovation from the International Society of CNS Drug Development. He is also an Adjunct Professor at the NYU Stern School of Business. Formerly, he was President & CEO of Cytel Corporation, a biotechnology company focused on immunology drug development, and a Management Consultant at McKinsey & Company, where he helped establish the Pharmaceutical Industry Practice. Dr. Kranzler has an M.D. with a focus in psychiatry and a Ph.D. in pharmacology from Yale University.
Expertise:
- Life Sciences
- Pharmaceuticals
- Biotechnology
- Medical Devices
- Diagnostics
- R&D Management
- Strategy